MERTK and glioblastoma: We demonstrate that with Foretinib therapy we can replicate the in vitro inhibition of survival and migration of glioblastoma seen following TAM RTK genetic inhibition, and we validate the therapeutic potential of TAM inhibition in in vivo models and the necessity of MerTK for glioblastoma tumor growth.